22nd Century Group Supports FDA Policy Advancements, Proposed Menthol Ban Now At OMB
Portfolio Pulse from Benzinga Newsdesk
22nd Century Group, Inc. (NASDAQ:XXII) has expressed support for the US FDA's move to ban menthol in cigarettes and flavored cigars. The FDA's proposed policies, which are currently under review by the White House Office of Management and Budget, aim to reduce disease and death associated with smoking and support smoking cessation. The company believes that these could be the most transformative proactive public health policies of a generation.
October 26, 2023 | 12:38 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
22nd Century Group's support for the FDA's proposed ban on menthol in cigarettes and flavored cigars could potentially position the company favorably in the market, given its focus on reduced nicotine tobacco products.
The company's support for the FDA's proposed regulations aligns with its business model of providing reduced nicotine tobacco products. If the regulations are implemented, it could potentially increase the demand for the company's products, thereby positively impacting its stock price in the short term.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100